After years of regulatory deadlock concerning political decision making on genome-edited and genetically targeted mutational breeding, the European Council has demanded that the European Commission regulate new plant breeding techniques (NBT), such as oligonucleotid-directed mutagenesis (ODM), gene scissors (CRISPR), and others.
Council presses EC to decide on genome editing
BackgroundAfter years of regulatory deadlock concerning political decision making on genome-edited and genetically targeted mutational breeding, the European Council has demanded that the European Commission regulate new plant breeding techniques (NBT), such as oligonucleotid-directed mutagenesis (ODM), gene scissors (CRISPR), and others.
Second clinical failure of Transgene in 2019
Latest NewsFrench Transgene SA said it has terminated its lead programme TG4010 in combination with chemotherapy and checkpoint inhibition.
Its simply mind over matter, guys!
OpinionThe European biotech sector is flourishing – rising stock prices, big partnering deals, and some major M&A. Can someone please tell European fund managers that investing in biotech is simply mind over matter?!
European Cannabis Association: An essential step
OpinionMedical cannabis has become one of the most important economic topics in recent years! But, what makes this topic so relevant, and why is it so essential to found a European association? The legalisation of recreational and medicinal cannabis in different states has led to impressive economic progress in recent years. Through worldwide patient campaigns and global marketing strategies, the topic became a permanent information focus for social networks and politics at the end of 2018.
Microbiota contribute to skin damage in cancer therapy
Latest NewsNew research demonstrates that disruption of EGF receptor signalling allows commensal bacteria to invade hairs and cause skin lesions.
ECBF: Investment pro
AppointmentsThe European Circular Bioeconomy Fund, which aims to provide financing for innovative circular bioeconomy companies and projects in the EU and in countries associated with the Horizon 2020 programme, will be headed by Michael Brandkamp.
BIOncoTech Therapeutics and MSD combine cancer drugs
Latest NewsMadrid-based RNA specialist Bioncotech Therapeutics has entered into a Phase II clinical trial collaboration with a MSD subsidiary.
Urokinase clears blot clots in stroke patients
Latest NewsSwiss surgeons have significantly improved mechanical removal of blood clots in stroke patients by intra-arterial administration of the thromolytic urokinase.
Mogrify: Decorated chair
AppointmentsAt the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech industry throughout her career.
Sanofi buys Synthorx Inc for US$2.35bn
Latest NewsSanofi will acquire Synthorx Inc to expand its immuno-oncology pipeline with THOR-707, an optimised IL-2 candidate.